John Mark Lievonen

John Mark Lievonen is a declared insider of Acerus Pharmaceuticals Corporation, with filings sourced from SEDI. In total, 6 filings cover trades dated from 6 December 2017 to 1 November 2019.

No open-market sale appears; the market trades are 5 purchases worth €5,955. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2019, the count stands at 2 purchases and no sales.

The median purchase comes to €741. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 4 November 2019, reports an open-market purchase of €1,089 in Acerus Pharmaceuticals Corporation. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.